Skip to main content
FinSpry Logo
FinSpry
IRD logo
IRD
(NASDAQ)
Opus Genetics, Inc.
$4.55-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Opus Genetics (IRD) Stock Price & Financial Analysis

Opus Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.51 - $4.76
52-Week High$5.30
52-Week Low$0.65
Open$4.60
Volume346.86K
Average Volume (3M)346.86K
Market Cap321.40M
Shares Outstanding70.64M
Price to Sales (P/S)22.64
Price to Book (P/B)55.52
EV/EBITDA-4.42
Revenue (TTM)14.63M
Net Income (TTM)-68.20M
EPS (TTM)$-0.97
Profit Margin-466.09%
Operating Margin-254.05%
Return on Equity (ROE)-1143.00%
Debt to Equity0.18
50-Day MA$3.81
200-Day MA$2.17
52-Week Change415.38%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Opus Genetics

What is the current stock price for IRD?

As of the latest trading session, IRD stock trades at $4.55. The 52-week range is $0.65–$5.30, with a day range of $4.51–$4.75.

What is the P/E ratio for IRD?

The P/E ratio (Price-to-Earnings) for IRD is shown in the Key Statistics section. This valuation metric helps compare Opus Genetics, Inc. to industry peers.

Does IRD pay dividends?

Opus Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IRD?

Based on 5 analysts, the consensus for IRD is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IRD?

Opus Genetics's market capitalization is $321.4M, classifying it as a small-cap company. Opus Genetics operates in the Healthcare sector within the Biotechnology industry.